O'Neill Vincent
SEC insider (Form 3/4/5 filer). CIK 0001672718. Officer at BioXcel Therapeutics, Inc. (BTAI). 7 reported Form 4/5 transactions since Sep 2024; latest on Dec 16, 2024. Located in NEW HAVEN, CT.
Companies O'Neill Vincent has filed insider reports for
- BioXcel Therapeutics, Inc. (BTAI): Officer, See Remarks
O'Neill Vincent
CIK: 0001672718
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BioXcel Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Dec 16, 2024BTAI
BioXcel Therapeutics, Inc.
SaleDirect165 shares at avg. $0.35$58.13 - Dec 14, 2024BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect521 shares- - Oct 3, 2024BTAI
BioXcel Therapeutics, Inc.
SaleDirect5.6K shares at avg. $0.55$3K - Sep 17, 2024BTAI
BioXcel Therapeutics, Inc.
AwardDirect21.3K shares- - Sep 16, 2024BTAI
BioXcel Therapeutics, Inc.
SaleDirect138 shares at avg. $0.69$95.33 - Sep 14, 2024BTAI
BioXcel Therapeutics, Inc.
ExerciseDirect521 shares- - Jul 22, 2024BTAI
BioXcel Therapeutics, Inc.
AwardDirectStock Option (right to buy)
1.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 16, 2024 | BTAI BioXcel Therapeutics, Inc. | Sale | 165 | $0.35 | $58 | Direct |
| Dec 14, 2024 | BTAI BioXcel Therapeutics, Inc. | Exercise | 521 | - | $0 | Direct |
| Oct 3, 2024 | BTAI BioXcel Therapeutics, Inc. | Sale | 5,556 | $0.55 | $3,056 | Direct |
| Sep 17, 2024 | BTAI BioXcel Therapeutics, Inc. | Award | 21,250 | - | $0 | Direct |
| Sep 16, 2024 | BTAI BioXcel Therapeutics, Inc. | Sale | 138 | $0.69 | $95 | Direct |
| Sep 14, 2024 | BTAI BioXcel Therapeutics, Inc. | Exercise | 521 | - | $0 | Direct |
| Jul 22, 2024 | BTAI BioXcel Therapeutics, Inc. | Award Stock Option (right to buy) | 1,875 | - | - | Direct |
1-7 of 7 transactions